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Respected members of the chair and 
distinguished colleagues, I am proud to address 
you at this august forum. Before I commence 
with my text, I have a few pleasant duties 
to perform. I acknowledge with gratitude 
Professors Venkoba Rao and Parvathi Devi 
for having instituted this award, and pay my 
humble respects to the memory of their son, 
the late Tilak Venkoba Rao, whose promising 
career was tragically aborted by an unfortu-
nate road accident. I thank my mentor and 
colleague, Dr. B. N. Gangadhar, who has 
guided me in much of my EGT research. 
Finally, I wish to pay a special tribute to all 
my teachers, down the decades, some of whom 
I am privileged to have in my audience today; 
few amongst us can claim to be entirely self-
made, and I unreservedly acknowledge my 
personal and professional indebtedness to the 
teaching profession. 
The efficacy of ECTis established in depre-
ssion and mania (Gangadhar et al, 1990a); 
there is also evidenc for its usefulness in schi-
zophrenia and other psychiatric disorders, 
and possibly in certain neurological and medi-
cal conditions as well (Weiner and Goffey, 
1988a; Andradc and Gangadhar, 1990a). 
Depression is the single largest indication 
for ECT. In depression, the superiority of 
ECT over antidepressant drugs is mooted on 
several counts with only Rifkin (1988) sound-
ing a note of caution- Recovery is faster 
with EGT than with antidepressant drugs 
(Gangadhar ct al, 1982, 1985a): with drugs, 
onset of therapeutic action is usually delayed 
to about 2 weeks after commencement of 
therapy, and peak response may not obtain 
until at least a month has elapsed, even gran-
ted absence of requirement for dose adjust-
ments; with ECT, however, response is seen 
from the first treatment itself (Rich and Black, 
1985; Andrade ct al., 1989a), and the patient 
is usually adequately recovered with 2-3 
Weeks treatment (Kendell, 1981). This 
differential rate of response becomes more 
pronounced with depressions of greater 
severity, and is important not just because 
ECT alleviates suffering faster, but because 
the patient is suicidal (if at all) for a shorter 
period (note also that a depressed patient can 
take an overdose of antidepressant drugs, but 
can not attempt suicide using EGT.), and 
because the time-cost-energy expenditure on 
the parts of both clinician and patient are 
less (Markowitz et al., 1987) with ECT. 
Further, ECT is more effective than antide-
pressant drugs in depression with psychotic 
features, and often succeeds when drugs fail 
(Consensus Conference, 1985). 
This advantage for ECT over drugs may 
not be at the cost of increased side effects; 
Calev et al. (1989) showed that the cognitive 
adverse effects of ECT and imipramine differ 
qualitatively rather than quantitatively, 
while Gangadhar et al. '1982 and Gangadhar 
(1985) found EGT-treatcd patients to report 
fewer subjective side effects than iinipraminc-
treated patients, indices of organic brain 
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impairment being comparable in the 2 groups 
in the intermediate and long term-
The posited superiority of ECT over drugs 
does not mitigate the disadvantages of ECT 
not all patients treated with ECT respond, 
and virtually all patients receiving ECT 
experience some (albeit mostly minor) of side 
effects. Today, there is hence a tendency to 
employ ECT' not as a positive indication but 
when depression is 'very severe', when psy-
chotic features are present, or when antide-
pressant drug therapy fails. 
The tendency to underutilize ECT can 
be combated by the development of strate-
gies for rational prescription and reduction in 
morbidity; my address will focus on the evalu-
ation of such strategies. 'Rational prescrip-
tion' is concerned with the maximization of 
the percentage of responders while 'reduction 
in morbidity' is concerned with the minimi-
zation of adverse effects. In my presentation, 
I will discuss the frontiers of research in these 
areas; rather than extensively review the field, 
I will focus on issues of practical importance 
and topics of personal interest. 
(A) STRATEGIES FOR RATIONAL 
PRESCRIPTION 
However careful the selection and however 
optimum the treatment procedure, some 
depressives treated with ECT fail to respond. 
Fink (1979; observed that over 80% of depre-
ssives treated with ECT show some degree of 
response while Stromgren (1984) opined that 
some 20°J, of endogenous depressives fail to 
respond to ECT. Most other authors cite 
similar figures. 
Looking at individual studies, however, 
startling differences emerge. Sackeim ct al. 
(1987a
-
1 found responders to comprise just 
28",, of a population of depressives treated 
with one form of ECT", while we (Andrade, 
1986) found 93",, of depressed patients to res-
pond to another form of ECT. The findings of 
most other studies lie in between these two 
extremes. The reasons for these divergent 
figures presumably lie in the selection of cases 
for ECT, in the ECT technique itself, and in 
the post-ECT psychiatric care. Accordingly, 
strategies for rational prescription may b< 
considered under the headings of response 
prediction, response facilitation and relapse 
prevention-
(I) Prediction of response of depression 
to ECT 
Problems in the interpretation of research 
Several problems cloud the interpretation 
of studies in this and in later sections. One 
is that different authors define response diffe-
rently. This is unfortunate as, for example 
predictors of outcome may vary in the same 
population depending on the outcome mea-
sure defining response (Coryell and Zimmer-
man, 1984). While Abrams (1989), discus-
sing various outcome analysis procedures, 
has proposed a mathematical model as an 
alternative to the definition of response, a con-
sensus definition is nevertheless needed to 
make results of studies comparable and clini-
cally relevant (Andrade and Gangadhar, 
1989). 
Another problem is the placebo effect. 
Although selection biases may explain the 
high proportion of sham-ECT responders in 
some studies (Kendell, 1981), many sham-
ECT-treated patients undeniably improve 
(Johnstone et al., 1980). Any group of ECT 
responders, therefore, also includes depres-
sives who may have responded to sham ECT. 
Hence, predictors of response that have been 
developed actually predict response to true 
and/or sham ECT, or merely identify good 
prognosis depression. The Northwick Park 
group, to-date, has been the only group to 
attempt prediction of response to true ECT 
alone (Clinical Research Centre, 1984). 
Yet another problem is the diagnostic 
category addressed. Studies on depressives 
unselccted by diagnosis (e. g. Mendels, 1965a
1) 
obviously yield results applicable only to 
depressives unselccted by diagnosis. Although PSYCHOBIOLOGICAL FRONTIERS OF ECT  111 
such studies are of limited relevance presently, 
their heuristic value in their day was undeni-
aole as they were conducted in an era in which 
the nosology of depression was in flux. 
Recent studies on specific depressive diag-
nostic subcategories of course yield results 
applicable only to such depressives. Regret-
tably, studies have been conducted on 'depre-
ssives referred for ECT' without diagnosis-
based selection (e. g., Robin and de Tissera, 
1982). Also, many authors select patients 
diagnosed as Major Depressive Disorder 
(DSM III/DSM III R), which diagnosis is 
probably a heterogenous category, and which, 
from experience in our country, includes a 
number of patients whom we understand to 
be neurotic. Results from such studies under-
standably cannot be generalized. 
Finally, despite the production of compar-
able motor seizures, all ECT may not be 
therapeutically equal. Therefore, variations 
in ECT Technique, or in any aspect of metho-
dology or analysis, could make results diffi-
cult to interpret or compare. 
Categories of response prediction 
Clinical, psychological, physiological, 
electroencephalographic, neurochemical, 
neuroendocrine and other predictive mea-
sures have each been described (Fink, 
1979, 1982 & 1986; Hamilton, 1982; Abrarns, 
1982 & 1988; Scott, 1989). Unfortunately, 
few predictors (if any) have been consistently 
validated, and an opinion has even been 
expressed that once an endogenous syndrome 
is defined, little variance remains to be explai-
ned on the basis of other predictors (Abrams, 
1989, personal communication). 
This is an era of sophistication in techno-
logy, and a dazzling array of investigations 
has been described in the attempt to predict 
the outcome of depression with ECT. Few 
of these, however, are relevant to our country 
because of unavailability, inaccessibility or 
unafTordability. Therefore, at our centre 
wc addressed clinical predictors of response 
to discover whether further refinement in 
prediction could be obtained after an endo-
genous was defined. 
The clinical prediction of response of endogenous 
depression to ECT 
In an endogenous population, sociodemo-
graphic variables such as age and sex do not 
differentiate responders from non-responders, 
nor do illness variables such as episode number 
and duration (Andrade et al., 1989b); with 
a few exceptions (no doubt results of chance 
distributions), these have never been seriously 
considered as outcome predictors (Dunn and 
Quinlan, 1978; Rich et al., 1984a; Coryell 
and Zimmerman, 1984; Prudic et al., 1989). 
Interestingly, we found bipolarity to 
significantly predict response (Andrade et 
al., 1989b). A possible interpretation is that 
the diagnostic criteria for endogenous depres-
sion are not sufficiently precise to define a 
biological (or, at least, an ECT-responsive) 
illness, and that a past history of mania refines 
a 'clinically endogenous' sample to a 'biolo-
gically endogenous' one. There is unfor-
tunately poor support for this finding in litera-
ture (Abrarns et al., 1973; Abrams and Taylor, 
1974; Pande et al., 1988), possibly because the 
sample in these studies was not rigorously 
screened for endogenosity. 
The presence of psychotic features (delusions, 
hallucinations, stupor) indicates ECT as the 
preferred treatment. However, there is no 
evidence that presence of psychotic features 
promises a greater likelihood or degree of 
response (Rich et al., 1984a & 1986; Solan 
et al., 1988; Black and Winokur, 1989), or 
that presence of reactive factors, concurrent 
medical illness, or personality disorders augurs 
poorly (Tich et al., 1984a; Zimmerman ct 
al., 1986). Interestingly, endogenous symp-
toms are not more likely to respond to ECT 
than non-endogenous symptoms (Prudic et 
al., 1989). These studies do not imply that 
endogenous or psychotic depressions are not 
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patients referred for ECT may be good res-
ponders even if endogenous or psychotic 
features are absent or other primary/associa-
ted features or diagnoses are present. 
Nosological systems admit other depressive 
subcategories (e. g. schizodepression, postpsyc-
hotic depression, reactive psychotic depres-
sion secondary depression etc.), but, to-date, 
no research lias satisfactorily addressed the 
efficacy of ECT in such depressions or the 
prediction of outcome thereof. A study on 
drug-resistant depression found that only 60% of 
patients responded to ECT; responders diffe-
red from non-responders in that they were 
less depressed initially; in no other clinical, 
sociodemographic or seizure parameters did 
differences obtain (Shapira et al, 1988a). 
N'on-nosological aspects of symptom pro-
file also fail to predict outcome. We found 
that negative symptom and social disability pro-
files do not differ between ECT responders 
and non-responders (Andrade etal., 1990a). 
While certain studies (e.g. Pande et al., 1988), 
including ours (Andrade et al., 1990a) find 
individual aymploms to differ in initial severity 
between ECT responders and non-respon-
ders, no symptom is consistently associated 
with response; such findings are best consi-
dered to be due to chance in view of the large 
number ol symptom comparisons being made. 
Delusions, however, but no other characteris-
tic, have specifically been identified to predict 
good prognosis with real ECT (Clinical Rese-
arch Centre. 1984). 
Many studies have associated lesser initial 
severity of depression with good response (Pande 
et al., 1988; Shapira et al., 1988a), which 
has been out observation as well (Andrade 
etal., 1989b). The application of this finding 
is obscure, given the low margin of difference 
in mean initial ratings of severity between 
responders and non-respondeis in these studies. 
The direction of this findings is unfortunate 
as less depressed patients are more likely to 
receive drugs, while more depressed patients 
are more likely to be treated with ECT. This 
finding, however, docs not indicate that ECT 
should not be used in more depressed patients 
for, although ECT may be less effective in 
these as compared with lesser depressed 
patients, it may yet be more effective than 
pharmaco-therapy. 
Many prognostic scales have been proposed 
to predict the outcome of ECT-treated depie;-
sion; these arc listed elsewhere (Clinical Re-
search Centre, 1984; Pande et al., 1988). 
Since these scales were developed in an era in 
which the nosology of depression was unclear, 
it has been opined that the scales do little 
beyond defining an endogenous syndrome 
(Abrams, 1982). However, many items 
in the scales differ from indices considered 
to define endogenosity (e.g., see Carney et a)., 
1965). We hence sought to discover whether 
superimposition of certain of these scales 
upon an endogenous (R.D.C.) population 
refined prognostication. Using Hobson's 
(1953), Mendels' (1965b; 1967) and the New-
castle Prognostic and Diagnostic (Carney 
et al., 1965; the latter was applied with the 
hypothesis that superimposition of the New-
castle endogenous depression concept upon 
the RDC endogenous depression concept 
would identify a core endogenous group 
likely to respond well to ECT) indices scored 
qualitatively (using the authors' cut-offs) 
and quantitatively as these indices may be 
more meaningful if considered as continuous 
variables), wc found the Newcastle Prognos-
tic Index to identify ECT responders with 
high specificity but disappointingly low sen-
sitivity, while the other indices, by virtue of 
indiscriminately classifying all/ almost all 
patients as responders, were high in sensitivity 
but low in specificity. The indices failed to 
differentiate responders from non-responders 
when quantitatively anahv.cd, nor did'heigh-
tening' of endogenosity using the Newcastle 
Prognostic Index refine prediction (Andrade 
ct al., 1988a, 1989b & 1990a). These findings 
suggest a utility for only the Newcastle Prog-
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off), and only when one wishes to be as certain 
as possible that no patient unlikely to respond 
will be exposed to ECT. 
While many have found these indices 
unhelpful in unselected depressives (e.g. 
Abrams et al., 1973), some (e.g. Katona and 
Aldridge, 1984) support our observations of 
the specificity with which the Newcastle Prog-
nostic Index identifies ECT responders in 
an endogenous cohort. In contrast to our 
findings, however, Katona and Aldridge 
(1984) obtained a high sensitivity for the 
Newcastle Prognostic Index. No good rea-
son is apparent for the lack of agreement bet-
ween the 2 studies. 
Sensitivity versus specificity apart, these 
indices suffer from limitations related to oper-
ationalization of constructs and to meaning-
fulness. When exactly, for example, is a 
personality previously ill-adjusted (Hobson, 
1953), or how does one accurately evaluate 
neurotic traits in childhood (Mendels, 1965)? 
ECT prognostic indices are hence unhelp-
ful once an endogenous population has been 
defined; a guarded exception may be made 
for the Newcastle Prognostic Index, but re-
evaluation of its sensitivity and specificity is 
required. 
As a responder to ECT is likely to improve 
from the first treatment itself, we studied 
whether response to the first £C7" could reliably 
predict outcome. We found a significant 
difference in depression scores between ECT 
responders and non-responders after the 
first ECT, severity of depression being com-
parable in the 2 groups prior to treatment; 
15% or greater attenuation of initial depres-
sion scores identified ECT responders with 
high specificity and, once 'doubly depressed' 
patients were excluded, high sensitivity as 
well (Andrade ct al., 1989a). If future re-
search confirms our findings, "trial ECT' for 
endogenous depression may become a viable 
predictor. Our conclusion is indirectly sup-
ported by the work of Rich and Black (1985) 
which showed that the first ECT' produces 
the maximum antidepressant response. 'Trial 
ECT' may however be unacceptable to 
patients and clinicians and, even if accepted, 
difficulty in ensuring patient (from whom 
informed consent would have been taken) and 
rater blindness to the purpose of the exercise 
may complicate interpretation of scores. 
Finally, allied to the prediction of good 
response to ECT is the prediction of poor res-
ponse. This has received virtually no research 
attention no doubt on the spurious grounds 
that one who is not predicted to be a good 
responder must necessarily be a poor or non-
responder. The identification of non-res-
ponse is useful to ensure that no patient 
unnecessarily receives ECT. To date, no 
satisfactory guidelines are available beyond 
the clinical dicta that 'neurotic', 'reactive' 
and 'secondary' depressions are not indi-
cated for ECT: some studies have however 
found that absence of endogenousor psychotic 
symptoms, or presence of associated medical 
or personality disorder, or secondary or reac-
tive status of the depression do not predict 
poor response (Rich et al., 1984a & 1986; 
Zimmerman et al., 1986; Solan et al., 1988; 
Black and Winokur, 1989). 
With the exception of the prognostic scales, 
predictors of response have by and large been 
considered univariately. It is possible, 
however, that presence or absence (or degree 
thereof) of one predictor may alter the predic-
tive potential of another predictor. There-
fore, large sample multivariately analyzed 
studies are necessary to evolve fresh response 
predictors with relative weights specified 
(as had been done, for example, by Carney 
et al., 1965), to refine prognostication in the 
light of recent research. 
Good response to ECT must be considered 
vis-a-vis good response to pharmacotherapy 
in the identification of response predictors—-
else, merely good prognosis depression will 
have be.-n identified (no mean goal itself, 
actually;, and not specifically ECT-respon-
sive depression. Alternatively, it must be 114  CHITTARANJAN ANDRADE 
acknowledged that predictors of good response 
to ECT also include predictors of good res-
ponse to drugs. 
(II) Facilitation of response of depres-
sion to ECT 
The practice of EOT is not standardized 
and different procedures yield different res-
ults. Seizure duration, electrode placement, 
stimulus waveform and electrical dose are 
factors implicated in such differences. Each 
is considered in turn. 
Seizure duration 
The central seizure is an essential thera-
peutic ingredient of ECT: modification of 
the peripheral seizure does not inhibit anti-
depressant action; non-convulsive stimuli 
arc ineffective; all seizures have antidepre-
ssant action whether electrically induced, 
chemically induced or spontaneous in 
origin; lidocaine-abbreviated seizures are 
sub-therapeutic (Kendell, 1981). These findi-
ngs, together with the observation that sup-
raliminal stimuli are not more therapeutic 
than conventional ones (Ottoson, 1960), 
prompted the myth that the seizure is an all 
or none phenomenon, and that as along as a 
seizure is induced, the dose of electrical sti-
mulus delivered does not matter to the efficacy 
of the treatment. Hence (as higher electri-
cal doses were recognized to produce more 
adverse effectsi a trend developed to use 
minimal, individually-titrated electrical sti-
muli to induce a convulsion. The fallacies 
herein will be taken up later (also sec Robin 
and de Tissera, 1982.- it suffices to state here 
that all convulsions arc not therapeutically 
equal; a certain minimum seizure duration 
is necessary for the seizure to be therapeutic, 
and the cut-oil' point for adequacy' is gene-
rally stated to be 25 sees. (Freeman ct al., 
1989.. 
What then of shorter or longer seizures? 
Seizures 23 sees, in duration arc not consi-
dered adequate; if 13 sees, in duration, 
restimulation is recommended (Freeman et 
a!., 1989). In our experience, seizures bet-
ween 15 and 25 seconds in duration are pos-
sibly also therapeutic (manuscript in prepa-
ration); at the other extreme seizures 100-
120 sees, in duration are associated with una-
cceptable risks for cognitive and other adverse 
effects. It is not known whether deliberate 
prolongation of seizures (achieved chemically, 
or by increased stimulus doses vide infra) 
beyond 25 sees, increases therapeusis: a.v., 
although seizures should last for 25—100 
sees., there is no evidence to-date to suggest 
that this range for the individual seizure is 
a therapeutic window in terms of efficacy or 
efficiency. 
Instead, it appears that once the minimum 
duration is defined for adequacy, seizure dura-
tion is not a reliable index of the therapeutic 
potency of the convulsion. While several 
strands of evidence lead to this conclusion 
(e.g., Rich and Black, 1985; Weiner et al., 
1986a), the most telling evidence perhaps, 
derives from studies which have demonstra-
ted that seizures produced by different ECT 
techniques may be comparable in duration 
but are disparate in efficacy (Sackein 
et al., 1987a; Andrade et al., 1988b). An 
explanation is that the pattern and extent 
of neuronal activation (which varies with 
EGT technique even though seizure durations 
may be comparable—e.g., see Robin et al., 
1985; Swartz and Larson, 1986; Abrams, 
1986) is probably more closely linked to 
therapeutic potency than seizure duration 
itself; that the seizure is not a therapeutic 
all or none phenomenon is hence estab-
lished. 
Maletzky (1978) suggested that the ECT 
dose is associated with a therapeutic window 
in terms of cumulative seizure duration, and 
set this window at 210—1000 sees. Since 
Maletzky failed to demonstrate the superio-
rity of cumulating seizure duration over cumu-
lating number of treatments administered, 
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has counted seizures in an unnecessarily 
elaborate way (for, granted that Maletzky's 
average seizure was 85 sees, in duration, 
his work suggests little beyond the obvious 
fact that treatment response is seen between 
the third and the twelfth ECT). While 
the cumulative seizure duration therapeutic 
window concept seems to be falling into obli-
vion, one must recognize that counting ECTs 
by number may be quantifying the ECT dose 
in an unnecessarily simplified way; to-date, 
however, there is no better alternative (manu-
script in preparation). 
Several methods have been used to measure 
seizure duration. Electroencephalography 
(e. g. Scott etal., 1989) is commonly employed 
in the West, but there is controversy about 
its usefulness as inter-rater reliability in assess-
ments (e.g. occurrence and duration of seizu-
res, or the endpoints thereof) has been repor-
ted to be low (e. g. Guze et al., 1989 ;McCreadie 
et al., 1989). The cuff method (Addersley 
and Hamilton, 1953), an index of the dura-
tion of the motor seizure, is also commonly 
employed, but tends to underestimate the 
EEG seizure by 10-30% (Fink and Johnson, 
1982; Liston et al., 1988). While controversy 
dogs the cuff method as well (e.g. Barrington, 
1987), this is generally the reference method 
for defintiionof adequacy of seizure duration. 
Other techniques to estimate seizuere durat-
ion include electro-cardiography (measuring 
ECT-induced tachycardia—e.g., Larson 
etal., 1984) and electrodermography (measu-
ring galvanic skin response—e.g. Guze et al., 
1988). The cuff method is easy, convenient 
and reasonable reliable in application, and 
may be recommended for routine use in our 
country. 
Routine seizure monitoring is necessary 
to identify missed or incomplete (abortive) 
seizures. Such are commoner in the elderly 
and in males, for seizure threshold is higher 
in these populations (Sackeim et al., 1987c; 
Pettinati and Nilssen, 1987); after several 
ECTs, for seizure threshold increases with 
successive ECTs, especially in responders 
(Sackeim et al., 1987b & c); when the skin is 
greasy or when the electrodes are not firmly 
applied, for poor electrode-skin contact in-
creases electrical impedance and hence decrea-
ses the effective stimulus itensity (Gangadhar 
and Andrade, 1989a & b); when the electrical 
stimulus is low in intensity, for the seizure 
threshold may not be crossed; with bilateral 
electrode placement, which is associated with 
greater seizure thresholds (Sackeim et al., 
1987c); with unilateral electrode placement 
at low stimulus doses, for generalization o* 
the seizure may fail to occur (Weiner, 1986a); 
as a result of hypoxia, anaesthesia or concurre-
nt benzodiazepine or anticonvulsant therapy, 
all of which raise the seizure threshold (Fink, 
1987). 
The immediate management of a missed/ 
incomplete seizure is to hyperventilate and 
hyperoxygenate the patient (to decrease the 
seizure threshold—see Rasanen et al., 1988 
and Chater and Simpson, 1988), ensure alow 
impedance electrode-skin interface, re-ad-
minister the muscle relaxant (if required) and 
redeliver the stimulus at the next higher set-
ting (the choice of which will depend on the 
ECT technique employed—see Gangadhar 
and Andrade, 1989a). 
In a few patients, missed/incomplete 
seizures are a recurrent problem; increasing 
stimulus dose to the maximum predisposes 
to increased cognitive and other morbidity 
and may yet not yield an adequate seizure. 
Many strategies are available to manage such 
a problem (Fink, 1987; Freemanet al., 1989) 
These include eliminating concurrent benzo-
diazepines, hyperventilating and hyperoxy-
genating before each treatment, reducing the 
dose of barbiturate anaesthesia or switching 
to kctaminc or etomidate (but not propofol — 
see Rampton et al., 1989), using unilateral 
electrode placement, 'double stimulating', 
or using drugs to facilitate seizure prolonga-
tion- Such drugs include concurrent anti-
depressant drugs (e. g. trazodone—sec Hohly 116  CHITTARANJAN ANDRADE 
and Martin, 1986), oral phcnothiazi ICS (Free-
man et al., 1989) and intravenous caffeine 
sodium benzoate (Shapira et al., 1987; Coffey 
et al., 1990). Use of other xanthine alkaloids 
(e. g. theophylline and aminophylline) may 
not be advisable because of the risk of status 
cpilepticus (Devanad et al., 1988; G. Edward 
Coffey, personal communication"). Sleep 
deprivation, which facilitates epileptiform 
activity in the EEG, does not prolong seizure 
duration (Kellner and Malcolm, 1988). Dis-
pensing with anaesthesia is unethical and 
should not be resorted to unless all other 
options fail. 
Electrode placement 
There is controversy about the ideal elec-
trode placement for facilitation of response 
to ECT. Scanning the literature, Welch 
(1982) and VVeiner (1986b) failed to find 
convincing evidence for the posited superio-
rity of bilateral (BL) over unilateral (UL) 
ECT; VVeiner (1986b) observed that with 
increased rigor in methodology, the thera-
peutic equivelance of UL and BL ECT be-
comes more pronounced. Stromgren (1984) 
has even queried whether BL ECT is ever 
indicated. 
Provided that the work can be replicated , 
much of the literature on this controversy 
has recently been rendered redundant. Since 
routine trials are biased in favour of UL ECT 
as seizure threshold is less with UL than with 
BL electrode placements (hence, in fixed ECT 
electrical dose trials, resulting in UL patients 
receiving materially more suprathreshold 
stimuli than BL patients), Sackeim et al. 
(1987a1 comparing UL (nondominant) and 
BL ECT with stimulus dose titrated to the 
individual patient's seizure threshold at each 
ECT setting, found that BL ECT' was over-
whelmingly superior to UL ECT. Tandon 
et al. (1988;, who did not titrate for the seizure 
threshold also found an advantage for BL 
ECT 
UL (non-dominant; UL dominant ECT is 
seldom given, and is discussed later) ECT 
causes less cognitive disturbance than BL 
ECT. Hence, if the UL ECT technique is 
improved such that its efficacy in depression 
is on par with that of BL ECT, UL ECT would 
become the procedure of choice. Weiner 
(1986a) has suggested the following improve-
ments: with UL ECT, the d Elia electrode 
placement is best; the electrode-scalp inter-
face must be particularly prepared to ensure 
low electrical impedance; the seizure must 
be monitored to ensure both generalization 
and adequacy in duration; the stimulus dose 
must be moderately suprathreshold (vide 
Sackeim et al., 1987a). A problem here is 
the operationalization of 'moderately supra-
threshold', for the closer the stimulus is to 
'considerably supra threshold', the greater 
the cerebral disturbance and possible loss of 
safety advantage (Weiner et al., 1986a) with-
out the advantage of therapeutic gain (Cron-
holm and Ottoson, 1960). Next, as seizure 
threshold varies widely across subjects and 
across time (Sackeim et al., 1987c), what is 
moderately suprathreshold for one patient 
may be barely suprathreshold for another 
and highly suprathreshold for a third. Seiz-
ure threshold will hence have to be identified 
for each patient several times during the ECT 
course, potentially exposing the patient either 
to subconvulsivc stimuli (necessitating resti-
mulation) or to seizures with barely threshold 
stimuli, neither of which favours the purpose 
of the exercise as one predisposes to cogni-
tive morbidity while the other predisposes to 
impaired therapeutic efficacy. 
With these modifications, Weiner et al. 
(1986a & b) found UL ECT to be as effective 
as but less cognitively 'toxic' (in the short 
and long term) than BL ECT. If this study 
can be replicated, reservations about the effi-
cacy of UL ECT (see also Abrams, 1986) may 
be dispelled. 
It is suggested that a subgroup of patients 
may exist who do not respond to UL brief-
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to BL sinusoidal wave (SW) ECT (McA-
llister et al., 1985; price and McAllister, 
1986; McAllister and Price, 1986). As the 
stimuli were not described in these reports, 
it is not possible to conclude whether this hypo-
thesis is indeed correct or whether the UL BP 
non-responders actually had high seizure 
thresholds and were not adequately stimula-
ted. Continuation of UL ECT (Andrade 
et al., 1987a) with the recommendations of 
Weiner (1986a) may well have evoked res-
ponse. If these findings are, however, not 
an artefact of ECT technique, effort is needed 
to identify state of trait markers of non-res-
ponse to UL BP ECT, and to eliminate the 
confounding influence of waveform-electrode 
placement interactions. 
The efficacy of UL ECT with sparing of 
certain cognitive functions indicates that not 
all parts of the brain require stimulation for 
the ECT to be therapeutic. Hence, techni-
ques for selective stimulation of specific brain 
structures may, if developed, suffice for thera-
peusis, thus maximizing efficacy while mini-
mizing adverse effects and removing the need 
for a convulsion. 
Finally : with UL ECT, the non-dominant 
hemisphere is usually selected for stimulation 
because dominant ECT causes prominent 
cognitive deficits (negating the very purpose 
of UL stimulation) and may also be less thera-
peutic (Weiner, 1986b). Recently, however, 
Abrams et al. (1987) found that right-sided 
LEG slowing was associated with right UL 
ECT and with less therapeusis, while left-
sided EEG slowing was associated with BL ECT 
and with more therapeusis, suggesting a 
therapeutic advantage for left hemispheric 
stimulation, which hypothesis was confirmed 
by Abrams et al. (1989) who reported that 
right UL ECT was associated with slower 
response than left UL ECT. The revolu-
tionary implications of this latter study must 
be tempered by the observations that the 
authors used very high (fixed) stimulus doses, 
that the margin of difference between r
;ght 
and left UL ECT, while statistically signifi-
cant, was clinically small, and that differences 
were obtained only in rale and not in degree 
of response. 
Stimulus waveform 
The cardinal difference between sinusoidal 
wave (SW) and brief-puls? (BP) ECT is that 
the latter induces convulsions with lesser sti-
mulus doses; the electrical aspects of stimulus 
waveform have recently been reviewed (Gor-
don, 1982; Weaver and Williams, 1982; 
Gangadhar and Andrade, 1989a). 
Scanning available studies, Weiner (1986b) 
found SW and BP ECT to be comparable in 
efficacy with an advantage for SW found only 
when an inefficient BP stimuhis (Pulse 
width ^0.5 msec.) was used. We, however, 
(Andrade et al., 1987b; 1988b) reported more 
endogenous depressives to respond to BL SW 
(93%) as compared with BL BP (60%) ECT. 
The work of Price and colleagues, proposing 
a subgroup of depressives to be responsive to 
BL SW but not ULBP ECT has already been 
discussed. Anand et al. (1986) and Price 
et al. (1986) reported on patients who res-
ponded to SW ECT after unsuccessful 'ade-
quate' courses of BP ECT (electrode position-
ing remaining unchanged). The common 
limitation in all these studies (except the UL 
BP vs BL SW reports, where stimulus details 
were not provided) and most of the case reports 
is that pulse widths ^0.75 msecs. and possi-
bly also minimally (BP) suprathreshold doses, 
were used, both of which may be suboptimum 
(Weiner and Coffey, 1989; R.J. Russel, per-
sonal communication). The work of Weiner 
et al. (1986 a & b), demonstrating therapeutic 
equivalence of SW and BP stimuli under 
optimum procedural conditions, is signal 
towards re-establishing the credibility of 
the BP stimulus. 
No study has compared different doses 
of SW ECT. Greatly suprathreshold pulse 
stimuli are not superior to moderately supra-
threshold (albeit described as 'liminal' by 118  CHITTARANJAN ANDRADE 
the authors) ones (Cronholm and Ottoson, 
1960). 
Of note : the vast majority of ECT instru-
ments available and in use in India utilize 
the unmodified sinusoidal waveform obtained 
from the electricity mains. 
Electrical dose 
From the previous discussions, one may 
conclude that (1) moderately suprathreshold 
stimuli (at least with right UL BP ECT) are 
more effective than liminal stimuli but not 
less effective than greatly suprathreshold 
stimuli (2) pulse widths <0.75 msecs. may 
be less effective than those between 1 and 1.5 
msecs. (3) the rate of stimulus delivery (in 
electrical terms, power) may also be charac-
terized by a therapeutic range (Weaver et 
al. (1985); Swartz and Larson (1989) have 
further found longer stimulus trains to be 
superior in seizure elicitation at a constant 
stimulus dose. 
The above 3 optimizations are all possi-
ble without an efficacy-adverse effect trade-
off. There is little doubt that the search for 
the ideal stimulus in terms of seizure-elicita-
tion with energy economy (Hyrman et al., 
1985) is illusory in the absence of description 
of satisfactory therapeutic benefit. 
The realization of the importance of the 
electrical dose has led to increasing sophis-
tication in ECT instrumentation; 'second 
generation' instruments have been developed 
(Keaver and Williams, 1987). These offer 
the clinician an extensive range of stimulus 
specifications. Constant current instruments 
are gradually replacing constant voltage ones 
as the former permit dosimetric precision in 
prescription; with constant voltage instru-
ments, at fixed stimulus settings the dose 
delivered is an inverse function of the impe-
dance. Electrical aspects of ECT and ins-
trumentation are discussed elsewhere (Rail-
ton et al., 1987; Weiner and Coffey, 1988b; 
Swan/, 1989a & b; Gangadhar and Andrade, 
1989 a&b). 
We have advanced the following hypothe-
ses to explain the relationship between elec-
trical dose and therapeutic response. The 
argument is adduced in 2 steps. First, there 
is evidence to suggest that the pattern and 
extent of neuronal activation with ECT is a 
function ol the ECT stimulus (e.g. Robin et 
al., 1958; Swartz and Larson, 1986; Weiner 
et al., 1986a). It is hence reasonable to 
presume that the neurochemical changes 
(elicited by the neuronal activation) which 
mediate recovery from depression are also a 
function of the ECT stimulus, a.v., the recovery 
process may be favourably sensitive to increa-
ses in current delivery over and above the 
seizure threshold- A therapeutic window in 
terms of electrical dose may thus exist for each 
individual for each ECT. The lower limit 
of this window is the seizure threshold (or a 
hypothetical response threshold-see below). 
This is because the ECT stimulus is a brief one 
and is unlikely to in itself evoke therapeutic 
neuronal/neurochemical change, while the 
seizure-activation of neuronal tissue is pro-
longed and hence perhaps responsible for the 
persistent stimulation of structures responsi-
ble for reversal of depression. This logic is 
in line with the observations that subconvul-
sive stimuli are non-therapeutic, and that 
convulsive BP stimuli are therapeutic while 
non-convulsive SW stimuli, although greater 
in intensity, are non-therapeutic The upper 
limit of such a therapeutic window is not 
clearly defined but is unlikely to exceed a 
'moderately' suprathreshold dose as such sti-
muli are not less therapeutic than grossly 
suprathreshold stimuli. 
Second, just as there exists a seizure thres-
hold which varies across individuals, so too 
may there exist a hypothetical electrically 
quantifiable response threshold (situated 
above the seizure threshold-see above) which 
similarly varies across individuals. A given 
stimulus may not be therapeutic (even if it 
elicits a seizure) unless it exceeds this response 
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either 'all or noae' in therapeutic terms or 
may reflect the lower limit of a therapeutic 
window as discussed above but located above 
the seizure threshold. 
Integrating these arguments, we hypo-
thesize that EC.T stimuli differ in efficacy and 
efficiency (i. e., degree and rate of response 
elicited) depending on whether or not they 
exceed a hypothetical response threshold situ-
ated at or above the seizure threshold {Res-
ponse Threshold—All or None Hypothesis) or 
depending on the degree to which they exceed 
a hypothetical response threshold situated at 
or above the seizure threshold [Response 
Threshold—Therapeutic Window Hypothesis). 
With the 'all or none' construct, the dis-
tance between the lowest and highest therapeu-
tic stimuli consists solely of inter-individual 
variation while with the therapeutic window 
construct it comprises intra-individual vari-
ation as well. 
These hypotheses have been progressively 
refined, albeit in small steps, over the years 
(Andrade, 1986; Andrade et al., 1987b; 
Andrade et al., 1988b; present version). 
Sackeim and co-workers (Malitz et al., 1986; 
Sackeim et al., 1987a) have also proposed a 
therapeutic window to characterize at least 
right (non-dominant) UL ECT. It must 
be stressed that the evidence for these hypo-
theses is presumptive and not empirical, and 
careful studies need to be conducted to test 
them. 
Other issues 
Ergoloid mesylates (Sachs et al', 1989) or 
antidepressants (Nelson and Benjamin, 1989, 
but not Haskett, 1982) administered concur-
rently with ECT may enhance therapeutic 
benefit. Antidepressants drugs alone or 
lithium augmentation thereof may remit 
ECT-resistant depression even in those depres-
sives who were resistant to pre-ECT pharma-
cotherapy; this suggests that ECT may alter 
the sensitivity of refractory patients to anti-
depressant drugs (Shapira et al., 1988b). 
(Ill) Prevention of relapse of depres-
sion following ECT 
ECT should never be prescribed as a course 
but should be continued until further response 
is unlikely. Controversy dogs the definition 
of the treatment endpoint; once this cndpoint 
is reached, though, care is warranted to pre-
clude relapse, of which about 50% (the exact 
figures vary across studies) risk exists within 
6 months of discontinuing ECT. 
Formerly, +2, -J-n/3 or -fn/2 ECTs 
were recommended after n ECTs produced 
the desired response. Barton et al.'s (1973) 
report is widely cited as evidence of the lack 
of prophylactic benefit of 2 extra ECTs but 
the study has methodological shortcomings 
and the data, even as they stand, are capable 
of being differently interpreted. Yet, the 
non-necessity of extra ECT can be justified 
on the grounds that antidepressant drugs or 
lithium, prescribed after completion of the 
ECT course, ensure prophylaxis (Abou-Saleh 
and Coppen, 1988); these should hence be 
routinely employed. 
In some patients, especially those in whom 
(pre-ECT) pharmacotherapy had failed 
(Sackeim et al., 1989), maintenance drug 
therapy fails; here, maintenance ECT, admi-
nistered weekly to monthly for several months, 
may be successful (Decina et al., 1987; Fink 
et al. 1989). Other predictors of relapse 
possibly include presence of DSM III Axis 
II personality disorders (Zimmerman et al., 
1986) and a diagnosis of delusional depres-
sion (Spiker et al., 1985). Clearer identi-
fication of predictors of relapse is required, 
and possible ECT (e. g. ECT maintenance 
therapy) or other strategies for the manage-
ment thereof. A problem is the differentia-
tion of relapse (of the same episode from 
recurrence (of a fresh episode), and the differe-
ntial management thereof. 
(B) STRATEGIES FOR REDUCTION IN 
MORBIDITY 
Cognitive impairment in depression (see 120  CHlTTARANjAN ANDRADE 
Price, 1982 a&b) is improved by EOT (e.g. 
Mackenzie et al., 1985)- However, ECT 
itself produces cognitive impairment dis-
tinct from that due to depression, and which 
develops as depression-related impairment 
wanes (e.g. Squire et al., 1979; Mackenzie et 
al., 198.))- This impairment is functional, not 
structural (VVeiner, 1984; Selected Staff, 
1985; Dam, 1985; Kolbcinsson et al., 1986; 
Pande et al. 1990). 
While every ECT-treated patient may 
experience minor cognitive disturbance (often 
detected only on structured psychological 
testing!, the incidence of severe impairment 
may be as little as 0.5"0 (Fink, 1979). Vary-
ing—sometimes alarming—-incidences have 
been cited of EGT-induccd subjective/objec-
tive cognitive deficits (Price, 1982 a&b); 
these must be tempered by the realization that 
no study has ensured patient or (often) rater 
blindness. Given negative public impressions 
of ECT, the possibility must be considered 
that sham ECT also yields subjective/objective 
short or long-term cognitive "dysfunction' 
which contaminates the true magnitude of 
that produced by real ECT. 
Certain Strategics for minimizing ECT-
induced cognitive dysfunction are discussed. 
(I) Reduction in ECT requirement 
An important recent concept is that ECT 
may produce time-dependant therapeutic 
change. Preclinical single ECT studies have 
described dopamine autorcceptor and alpha-2 
adrenoceptor subsensitivity (both suggested 
to underline antidepressant action) occuring 
eoincidentally in time with the emergence of 
similar effects with serial ECTs. (Chiodo and 
Antelman, 1980; Pepper et al., 1982). We 
have found single ECT to produce time-depen-
dant effects (Andrade ei al., 1990b) but not as 
earlier described (Andrade and Pradhan, 
1990a ; Gangadhar et al.. 1990b", thus refuting 
the possibility that a single ECT may suffice 
to treat depression. 
Yet. clinical work has indicated possible 
benefit with a single ECT. Rich and Black 
(1983) observed that the first ECT in a series 
is the most therapeutic, and suggested that 
further benefit with successive treatments 
may reflect a carryover effect of the first treat-
ment. In a preliminary (unpublished) dou-
ble-blind, sham ECT-controlled study, we 
found many single ECT-treated depressives 
to showsatisfactory improvement as compared 
with 3/week ECT-treated patients, at the 
end of the 3 week trial. 
Less revolutionary but also on the time-
dependant theme is the proposal that 2/week 
ECT produces the same results as 3/week 
ECT (see Lerer and Shapira, 1986). In fact, 
in many centres 2/week ECT is conventional. 
In our laboratory, we have demonstrated that 
3 alternate day ECTs comparably subsensi-
tize alpha-2 adrenoceptors as 6 daily (conven-
tional schedule in animal experiments) ECTs 
(manuscript in preparation). 
McAllister et al. (1987), comparing 2/wk 
and 3/wk ECT-treated depressives, found the 
former to require fewer ECTs and experience 
less cognitive dysfunction than the latter. 
However, Shapira et al. (1989) found that in 
the 2 schedules the same number of ECTs 
were required to attain a specified degree of 
recovery (the 2/week patients hence improved 
slower). Even if 2/week ECT necessitates 
the same number of treatments as 3/week 
ECT, cognitive morbidity may be less with 
the former-consider, for example, that 3/ 
week ECT is cognitively less 'toxic' than daily 
ECT (Freeman et al., 1989). 
The time-dependant hypothesis is in the-
oretical opposition to the concept that a set 
number of treatments (or a set cumulative 
seizure duration) is required for therapeusis, or 
that response may be hastened by more fre-
quent ECT (Stromgren, 1975; Maletzky. 
1987). 
Concurrent antidepressant drugs do not 
decrease ECT requirement (Haskett, 1982) 
but Sachs et al. (1986) found yohimbine to do 
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facilitatory drugs may similarly, on theore-
tical grounds, be of use as such may facilitate 
postsynaptic beta adrenoceptor down-regula-
tion, which change is suggested to underlie a 
mechanism of antidepressant action. 
finally, unnecessary EOT can be avoided 
by optimum definition of treatment endpoint 
and termination of the ECT course. 
(II) Hastening of response to ECT 
Quicker response to ECT means less suffe-
ring, less risk for suicide and less time-cost-
energy expenditure. Further, ECT require-
ment and hence (presumably) cognitive mor-
bidity would be less. 
SWECT, high energy BP ECT, or, in gene-
ral, higher electrical doses are suggested to 
purvey faster recovery than BP ECT, lower 
energy BP ECT or lower electrical doses res-
pectively (Robin, 1981; Robin and de Tissera, 
1982; Robin, 1988). These findings have 
however not been confirmed (Wciner et al., 
1986a & b; Andrade et al., 1988c; Fox et al., 
1989). Similarly, the claim that BL ECT has-
tens recovery relative to UL ECT (Gregory 
et al., 1985; Abramset al., 1987; Tandon et 
al.,. 1988) remains in doubt (Weiner et al., 
1986 a & b; Sackeim et al., 1987a). Domi-
nant, as compared with nondominant unilater-
al ECT, may be associated with faster response 
Abrams et al., 1989). Multiple ECT, wherein 
several ECTs are given in each treatment ses-
sion to hasten recovery (Maletzky, 1986) is as 
yet unevaluated for benefit and risk in double-
blind, prospective studies. Administering 3 or 
4 ECTs/week may hasten recovery relative to 
2 ECTs/week, possibly without recourse to 
increased total ECT requirement (Stromgren, 
1975; Shapiraetal., 1989); this too is in dispute 
McAllister et al., 1987). Besides being ques-
tionably effective, these strategies to hasten 
recovery may increase cognitive dysfunction as 
will be discussed later. The role of yohimbine 
in hastening recovery has already received 
mention. 
Interestingly, Dinan and Barry (1989) found 
that in tricyclic non-responders augmentation 
with lithium elicited response faster than did 
ECT, the low rate of ECT response however 
suggests that the ECT technique used may have 
been suboptimum. 
(III) Prediction of fast response to ECT 
Most depressives require 6-8 ECTs, but 
some respond quicker and others, slower 
(Kendell, 1981). Cases have been described 
of dramatic 'melting' of symptoms with ECT 
(Rich, 1984; Keisling, 1984; Andrade et al., 
1987c). The prospective identification of poten-
tial slow/fast responders is poorly researched 
and is necessary to ensure that ECT is not dis-
continued prematurely in slow responders or 
late in fast responders, and that, if sparing of 
cognitive function is vital, slow responders 
receive ECT only if such is unavoidable. 
It is not known whether rate of response to 
ECTisstate-or trait-dependant (or linked more 
to ECT practice-vide supra !). Hitherto, only 
clinical differentiation of slow and fast res-
ponders has been attempted. In a limited 
analysis, Barton (1973) found that depression 
>6 months in duration was associated with 
either fast (requiring 2-4 ECTs) or slow (re-
quiring 9-12 ECTs) response. We (Andrade 
et al., 1988d) however observed no relation-
ship between duration of depression and rate 
of response; instead, male sex, and greater age 
associated with lesser initial severity of depres-
sion were associated with faster response (re-
quiring ^ 5 ECTs for full response), while, inter-
estingly, no such association was found for 
features suggested to predict good outcome with 
ECT. Our findings contrast with the opinion 
of Freeman et al. (1989) (possibly based on the 
reports of Price et al.. 1978 and Rich et al., 
1984b, which were methodologically quite diffe-
rent from ours) that older patients and men 
may require more treatment. 
(IV) Stimulus-related issues for mini-
mizing cognitive deficits 
BP ECT, even at moderately suprathrc-122  CHITTARANJAN ANDRADE 
shold doses, produces less acute cognitive morbi-
dity than SVV ECT; this advantage for BP ECT 
is lost in subsequent weeks (Weiner, 1986b; 
VVeiner et al., 19861;; or is even absent acutely 
if the BP stimulus is too intense (Squire and 
Zouzoimis, 1986). SW but not BP dos-. varia-
tions correlate with cognitive morbidity, imply-
ing that as long as stimuli are not more than 
moderately siiprathreshold, BP but not SVV 
stimuli may be below a cut-off lor intensity 
related effects on ECT-induced cognitive dys-
function (VVeiner et al., 1986b). However, 
Pettiuati et al. (1989; found that subjects with 
most forgetting after UL BP EC T were respon-
ded who had received higher stimulus doses. 
Non-cognitive subjective side effects and sub-
jective global memory ratings do not differ 
between SVV and BP groups (Andrade et al., 
1990c; VVeiner et al., 1986b)-
UL non-dominant (ND; ECT, as compared 
with BL ECT, spares many cognitive (parti-
cularly verbali functions (Price, 1982 a & b) 
and is associated with fewer subjective side eff-
ects Sackeim et al., 1987d) in the acute post-
EC T phase. VVeiner et al. (1986 a & bj have 
found that personal memory loss with BL but 
not UL ECT extends for as long as 6 months 
post-treatment; indices of impairment arc 
least with UL BP and most with BL SW ECT; 
this, coupled with earlier mooted evidence of 
the therapeutic equivalence of SVV and BP 
ECT, and of UL and BL ECT', recommends 
I'L BP ECT for routine practice in most 
depressions. 
UL XI) electrode positions may not differ 
in cognitive effects AVidepalm, 1987), but UL 
XI) ECT is unquestionably more benign than 
I'L dominant ECT - Pticc, 1982 a & b.. 
Current densities in the brain tissue lying 
in and around the interelectrode axis are much 
greater with UL than with BL ECT (Weaver 
and Williams, 1982 . but the fear that these 
currents m.iv be unacceptably high (Kt i-s et 
al., 1978; Breggin, 1986 has not been substan-
tiated in cognitive and other studies. Interac-
tion with reality are largely biased for verbal 
content; hence, UL ND ECT, which relativelv 
spares verbal cognition, is superior to BL ECT. 
What, then, of musicians, artists and other 
persons to whom integrity of ND henr'spheric 
functioning is paramount ? Might the advan-
tage of UL ND ECT be lost due to the produc-
tion of higher current densities in the ND hemis-
phere ? While available evidence is reassuring, 
imaginative cognitive assessment is yet to be 
conducted in suitably designed studies. 
(V) Minimizing cognitive deficit : 
other strategies 
Missed or incomplete seizures are a fre-
quent problem, and the clinician's reflex, when 
such occur, is to raise a stimulus setting and res-
timulate. While this is not incorrect, other 
strategics can ensure an adequate convulsion 
at ihe same stimulus settings; these have been 
discussed earlier. While many strategies are 
innocuous (e.g. ensuring adequate electrode-
skin conductance) or even beneficial (e.g. swit-
ching from BL to UL EGT), certain (e.g. caf 
feine-prolongation of seizures) have to be evalu-
ated against stimulus dose-augmentation in 
terms of benefits and cognitive adverse effects. 
Coffey etal. (1990; demonstrated that caffeine-
augmented low electrical dose UL BP seizures 
are associated with comparable efficacy and 
adverse effect profiles as seizures produced by 
higher stimulus doses. Unneceessary elevation 
in electrical doses should be avoided, while pro-
longation of an otherwise adequate seizure 
may not be desirable as such may enhance 
adverse effects without improving the efficacy 
or efficiency (Miller et al., 1985). 
Anticholinergic drugs impair cognition, but 
substitution of glycopyrrolate for atropine in 
ECT premedication does not lessen cognitive 
deficit (Sommeret al., 1989). Piracetam (Ezzat 
et al., 198.Vi, possibly ergoloid mesylates (Sachs 
et al.. 1989 and vasopressin (Mattes et al., 
1989 & 1990; but not ACTH and naloxone 
(Fredericksen et al., 1985: Nasrallah et al., 
1986 have tentatively been suggested to atte-
nuate ECT-induced cognitive dysfunction in PSYCHOBIOLOOlCAL FRONTIERS OF ECT  123 
varying degrees. Suedfeld ct al. (1987 & 1939) 
found restricted environmental stimulation 
therapy (wherein the patient is placed in a 
quiet, dimly lit room for 2-4 hours after ECT) 
to hen;Tit subjective but not objective memory 
function after ECT. This, actually, suggests a 
placebo and not a true therapeutic effect. 
Hitherto, ECT parameters have alone been 
considered as independent variables in ECT-
iiuluced cognitive impairment. Might state-
or trait-dependant patient variables also be 
relevant ? An attempt to identify patients at 
high risk for the development of cognitive dys-
function with ECT is warranted. 
CONCLUDING REMARKS 
In the West, legislation and adverse public 
opinion shackles the practice of ECT, and this 
important treatment is relegated to application 
in very severe and medication-resistant illness. 
By contrast, in India use of ECT is optimized 
to situations in which it is indicated positively 
and not merely by exclusion. With increased 
utilization of psychiatric services accompanying 
progress in the implementation of the National 
Mental Health Plan, use of ECT could concei-
vably increase to manage in a time-cost-energy 
effective way the burden of the mentally ill 
from a population in excess of 800 million. 
These are very good reasons why India should 
lead in standards of ECT practice and in clinical 
research. This has been a major objective in 
the subject and content of my address to you. 
Late this year, we will organize and host at 
XIMHANS a national level ECT Symposium 
to discuss advances in theoretical and practical 
aspects of ECT as a belated tribute to the year 
1988, the Golden Jubilee Year of ECT, which 
passed by without a whimper from the Indian 
scene. Details about this Symposium will be 
announced in the Indianjournal of Psychiatry. 
Finally, communication between psychia-
trists in our country is poor. On the subject 
of ECT at least, I offer to share the expertise 
that we have developed in our Institute by 
way of mailing reprints to requesters, pro-
viding guidelines, offering suggestions and 
collaborating in research wherever possible. 
Our country is rich in clinical material, and 
I repeat that where practising standards and 
clinical research in ECT are concerned, India 
must lead. 
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